Dendrite Dx – Advanced Alzheimer's Diagnosis in Delhi NCR
The Integrated Suite for Cognitive Health & Alzheimer's Diagnosis by Dr. Dangs Lab
Dr. Dangs Lab unveils an integrated diagnostics pathway for precision brain health — that begins with digital cognitive assessments and blood-based biomarkers to screen mild cognitive decline, then progresses to stepwise reflex testing for Alzheimer's, including FDA-approved biomarkers, targeted genotyping, and an exclusive LC-MS–based proprietary confirmatory test in collaboration with C2N Diagnostics (USA).
Early Detection with Dendrite Dx for a Healthier Brain
- Alzheimer's affects over 55 million people worldwide.
- Most cases are detected too late, as subtle early changes are often missed in routine checkups.
- Traditional methods like PET/MRI scans or lumbar punctures are expensive, invasive, and not widely accessible.
- Dendrite Dx bridges this gap by offering a non-invasive, affordable, and scientifically validated diagnostic pathway — combining a digital cognitive assessment with advanced blood biomarkers to detect risks years earlier.
Why Choose Dendrite Dx for Alzheimer Test ?
- 15–20 minute digital brain cognitive assessment (FDA cleared, ISO 13485:2016, ISO 27001:2013 certified)
- Scientifically validated, FDA-cleared biomarkers (pTau-217, Amyloid Beta 1-42 and APO E)
- A liquid chromatography-tandem mass spectrometry test combining amyloid beta and p-tau measures into a proprietary APS2 result for accurate Alzheimer's disease test analysis
- Early detection before major cognitive decline
- Non-invasive alternative to PET scans & spinal taps
- Helps identify reversible causes like vitamin deficiencies, thyroid dysfunction, and metabolic imbalance
"Alzheimer's that surfaces in the 70s may be signaled in the 40s by a simple blood draw."
Reference: Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer's Disease Pathology Nicholas J. Ashton, PhD - JAMA Neurology
Included in Every Package
Digital Brain Cognitive Assessment
- Quick 15–20 min validated test
- Measures memory, attention, executive function, processing speed & visuospatial skills
- Generates an age-adjusted cognitive profile with actionable insights
Reference: Chew, E. Y. C., Prem, P., Kuah, J., Vij, N., & Balasundaram, A. (2023). Comparison of DBFS with MoCA and MMSE tools for MCI screening. Biomedical Informatics, 19(5), 22.https://pubmed.ncbi.nlm.nih.gov/37886151/
Simple Blood Draw Using CLEIA (Chemiluminescent Enzyme Immunoassay) Method
- Accurate, reliable, and CLIA-certified
- Detects Alzheimer's biomarkers with greater accessibility and comfort
- A game-changing alternative to invasive lumbar punctures and costly PET scans
Note: This is a screening test with a high Negative Predictive Value (NPV).
Our Packages
Basic – Dendrite Dx for Alzheimer's Test
- Quick 15–20 min validated Digital Cognitive Assessment test.
- This blood test is non-invasive and measures the p-tau/beta Amyloid 1-42 ratio which is a new, US-FDA approved blood-based Biomarker and is linked to amyloid plaque deposition and tau related neurodegeneration.
- Done through a simple CLEIA-based blood draw - fast, accurate, and patient-friendly
Advanced – Dendrite Dx for Alzheimer's Test
- Quick 15–20 min validated Digital Cognitive Assessment test.
- This blood test is non-invasive and measures the p-tau/beta Amyloid 1-42 ratio which is a new, US-FDA approved blood-based Biomarker and is linked to amyloid plaque deposition and tau related neurodegeneration.
- ApoE (Apolipoprotein E) for Genetic Predisposition: A simple genetic marker that helps identify individuals with an increased inherited risk of developing Alzheimer’s disease, especially those carrying the ApoE4 variant.
Additional Cognitive & Health Markers:
Cognition specific: Ferritin, Homocysteine
Hormonal: Thyroid (TSH, Free T3, Free T4), Cortisol, PTH
Inflammatory: hs-CRP, Magnesium
Metabolic: HbA1c, Insulin(Fasting), Lipid Profile, Uric Acid, LFT
Nutritional: Vitamin B12, Folate, Vitamin D
General Health: CBC
These tests look at different aspects of your body that directly impact how your brain works—things like vitamin and hormone balance, blood sugar control, inflammation, and even kidney health. When any of these are off, it can show up as poor memory, low focus, mood changes, or a higher risk of long-term cognitive decline.
Final Confirmation via PrecivityAD2™ (C2N Diagnostics) — Add-On Not Included in Standard Packages
The PrecivityAD2™ test is a clinically available multi-analyte C2N blood test for Alzheimer's, performed by liquid chromatography-tandem mass spectrometry, that determines whether a patient is likely positive or negative for the presence of brain amyloid plaques — one of the neuropathological findings of Alzheimer's disease.
The testing process uses highly sensitive and specialized laboratory technologies to identify and measure certain proteins that are found in blood and that are known to be associated with the presence of brain amyloid plaques. The main test result is a score, called the Amyloid Probability Score 2 (APS2) — a key metric used in cutting-edge blood tests for Alzheimer's.
Note: For a complete diagnostic pathway that begins with clinical evaluation and progresses through to definitive confirmation, the PrecivityAD2™ test plays an essential role in establishing the likelihood of amyloid pathology.
At Dr. Dangs Lab, we've partnered with C2N Diagnostics for Alzheimer's Test, a global leader in brain health testing, to bring to India the revolutionary The PrecivityAD2™ Blood Test.
Offers a 360° brain & body health evaluation, helping detect both neurodegenerative and reversible causes of memory issues.
- Detects Amyloid Beta & pTau-217 proteins linked to brain plaque buildup
- Powered by mass spectrometry + AI-backed algorithm
- Gives you an APS2 Score (your likelihood of Alzheimer's-linked brain changes)
- No painful spinal tap. No costly brain scans.
Why Alzheimer's Diagnosis Matters?
- Earlier diagnosis - better outcomes
- Expanded access – reach underserved communities with a simple test
- Improved planning – helps families make timely decisions about care & lifestyle
- Supports research & trials – enables participation in disease-modifying therapies.
Who Should Get Tested?
- Adults with a family history of Alzheimer's/dementia
- Those with brain fog, memory lapses, or poor concentration
- Patients with lifestyle risks (diabetes, hypertension, obesity)
- Adults 55+ years for proactive cognitive health
Reduce Your Risk of Alzheimer's with Dr. Dangs Lab
You can lower your risk of Alzheimer's by keeping your brain, body, and heart healthy:
- Regular exercise
- A balanced diet, like the Mediterranean or MIND diet
- Good sleep
- Managing conditions such as diabetes, high blood pressure, and cholesterol
- Staying socially engaged and mentally active (learning, puzzles, reading)
- Reducing stress
- Avoid smoking, limit alcohol, and protect against head injuries
In short: what's good for your heart is good for your brain.
The FDA has approved two treatments that slow the progression of early-stage Alzheimer's by clearing amyloid plaques. Very soon, they will be launched in India.
Why Dr. Dangs Lab for Alzheimer Test ?
- 4 decades of diagnostic excellence in India
- Available pan-India
- Among the first to integrate digital + blood-based Alzheimer's detection
- Patient-centric approach: Accessible, affordable & scientifically rigorous
Take Charge of Your Brain Health Today
How to Get Started:
Final Thought
Dendrite Dx — Bridging the Gap in Alzheimer's Detection. Early, Accessible, Actionable.
Latest News
Stay updated with our latest breakthroughs in brain health diagnostics across platforms
Alzheimer's diagnosis in India
| Delhi | CEO of Dr Dangs Lab, Dr Arjun Dang says, There's a huge gap in Alzheimer's diagnosis in India. Currently, what is available is not very accessible... The other form of diagnosis is through your spinal fluid.
New test for Alzheimer’s, non-invasive and FDA-approved, now available in India
A new non-invasive test for detecting Alzheimer’s Disease, which has already been approved by the US Food and Drug Administration (USFDA), has been introduced in India. Developed by Dr Dangs Labs, the test is known as Dendrite Dx, a bundle of tests that includes a 15-20 minute quiz and can be taken easily by anyone for the diagnosis of the neurodegenerative condition.
Delhi lab launches non-invasive Alzheimer’s diagnosis
Dr Dangs Lab in Delhi has launched a non-invasive early detection test — Dendrite Dx — for Alzheimer’s disease on the occasion of World Alzheimer’s Day on Sunday, the company informed.
Non-invasive test to catch early signs of Alzheimer’s now in India. How it works, how much will it cost
The test, Dendrite Dx, launched by Dr Dangs Labs, includes a 15-minute FDA-cleared cognitive assessment, advanced blood biomarkers to detect key proteins suggesting the condition and a proprietary APS2 result through collaboration with a US-based diagnostic lab in patients with signs of cognitive impairment.